BioNTech’s (BNTX) Buy Rating Reiterated at HC Wainwright
HC Wainwright reissued their buy rating on shares of BioNTech (NASDAQ:BNTX – Free Report) in a report issued on Friday morning, Benzinga reports. HC Wainwright currently has a $113.00 target price on the stock. Other analysts also recently issued research reports about the stock. Canaccord Genuity Group restated a buy rating and set a $171.00 […]
More Stories
UAE Halts All Iranian Trade After 2 Missiles Launched From Iranian Territory
By Jill McLaughlin The United Arab Emirates (UAE) halted all trade with Iran after officials determined two missiles detected earlier...
Amazon to Expand Drone Deliveries to Nearly 500 US Cities
By Bill Pan Amazon is expanding its airborne delivery service, with a goal of using drones to deliver small packages...
US Gas Prices on the Rise, Diesel Sees Higher Increase
By Jack Phillips Gas and diesel prices are rising again, according to new data, amid uncertainty over the conflict in...
Trump Says He Brokered ‘Very Good Deal’ With Ottawa, Including Lowered Tariffs on Canada
By Matthew Horwood U.S. President Donald Trump says a preliminary trade deal made with Canada will benefit both countries, including...
How to Generate High-Authority Backlinks? Proven Strategies to Increase Organic Traffic
Creating attractive and useful content is a smart part of SEO. If websites with higher authority and credibility do not...
Health Officials Report More Cases of Flesh-Eating Beach Bacteria
By Jack Phillips Health officials have reported that cases of a rare type of flesh-eating bacteria found in warm seawater...